1,426 results on '"Slavin S"'
Search Results
2. Immunotherapy by Allogeneic Lymphocytes and Cytokines Following Autologous and Allogeneic Bone Marrow Stem Cell Transplantation
3. The Global Kinematics of the Globular Cluster M92
4. Three Years of ChaMPlane Northern Field WIYN Spectroscopy
5. The Global Kinematics of the Globular Cluster M15
6. Shifting Towards Better Immunotherapy Rather Than More Intensive Chemoradiotherapy Using a Non-Myeloablative Approach in Patients with Leukemia
7. Nonmyeloablative Allogeneic Stem Cell Transplantation: Towards Improving Efficacy of Immunotherapy Instead of Myeloablative Chemoradiotherapy
8. Understanding Concerns About Treatment-as-Prevention Among People with HIV who are not Using Antiretroviral Therapy
9. Donor Immunization Vaccination and Transfer of Donor Immunity to Bone Marrow Transplant Recipients in the Course of Allogeneic Cell Therapy for Prevention and Treatment of Relapse
10. The Use of Melatonin and Cotreatment with Autologous or Allogeneic Cells as a Model for Control of Malignant β-cell Leukemia
11. Toward Improvement of Therapeutic Strategies in Leukemia by Amplification of the Immune Responses Against Leukemia
12. Medical Student Perceptions of the Accuracy of Various New Clinical Evaluation Methods
13. Allogeneic CD3/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia/lymphoma
14. Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis
15. Selective elimination of alloreactivity in vitro and in vivo while sparing other T-cell-mediated immune responses
16. Supplement to: Lower-extremity lymphedema and elevated body-mass index.
17. The anti-tumor effect of allogeneic bone marrow/stem cell transplant without graft vs. host disease toxicity and without a matched donor requirement?
18. Completely mismatched allogeneic CD3/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity
19. The number of infused CD34+ cells does not influence the incidence of GVHD or the outcome of allogeneic PBSC transplantation, using reduced-intensity conditioning and antithymocyte globulin
20. Alefacept treatment for refractory chronic extensive GVHD
21. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
22. Time to engraftment following allogeneic stem cell transplantation is significantly longer in patients with myelodysplastic syndrome than with acute myeloid leukemia
23. Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study
24. Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimen
25. Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1)
26. The effect of high-dose thiotepa, alone or in combination with other chemotherapeutic agents, on a murine B-cell leukemia model simulating autologous stem cell transplantation
27. Treatment of post-hematopoietic stem cell transplantation hemorrhagic cystitis with intravesicular sodium hyaluronate
28. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
29. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome
30. Deletion of Donor-Reactive Cells as a New Conditioning Regimen for Allogeneic Bone Marrow Transplantation
31. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)
32. Rapid response to alefacept given to patients with steroid resistant or steroid dependent acute graft-versus-host disease: a preliminary report
33. Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamide
34. Survey on haematopoietic stem cell transplantation for children in Europe
35. Low transplant-related mortality with allogeneic stem cell transplantation in elderly patients
36. Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy
37. A new minimally ablative stem cell transplantation procedure in high-risk patients not eligible for nonmyeloablative allogeneic bone marrow transplantation
38. Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses
39. Cobalt-Catalyzed Chain Transfer Polymerization
40. Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
41. Immunotherapy of relapsed resistant chronic myelogenous leukemia post allogeneic bone marrow transplantation with alloantigen pulsed donor lymphocytes
42. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen
43. Safety and Efficacy of Donor Lymphocyte Infusions following Mismatched Stem Cell Transplantation
44. Fludarabine-Based Reduced Intensity Conditioning for Stem Cell Transplantation of Fanconi Anemia Patients from Fully Matched Related and Unrelated Donors
45. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients
46. Saving on energy resources in the oil and gas complex
47. Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man
48. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma
49. Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector
50. Mini-allografts: ongoing trials in humans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.